That’s not how markets work, right? And I don’t think it’s true in either example. If you can charge more, you will. Price should match value.
OpenAI is charging a _really_ high monthly fee for ChatGPT, and it’s quite popular. It’s very limited - there’s no way the cost incurred for usage is near that. Obviously their costs include the R&D that has already happened, but I still think it’s priced way over that.
Drug manufacturers are famously making money hand over fist. Patients aren’t their customers. Insurance companies are. They are surely gouging insurance companies to their fullest capacity.